{"id":531441,"date":"2021-08-25T16:08:44","date_gmt":"2021-08-25T20:08:44","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/"},"modified":"2021-08-25T16:08:44","modified_gmt":"2021-08-25T20:08:44","slug":"opiant-pharmaceuticals-to-participate-in-september-investor-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/","title":{"rendered":"Opiant Pharmaceuticals to Participate in September Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SANTA MONICA, Calif., Aug.  25, 2021  (GLOBE NEWSWIRE) &#8212; Opiant Pharmaceuticals, Inc.\u00a0(\u201cOpiant\u201d) (Nasdaq: OPNT) today announced that members of the company\u2019s senior management team will participate in the following virtual investor conferences:<\/p>\n<ul type=\"disc\">\n<li>\n          <strong>H.C. Wainwright 23rd Annual Global Investment Conference<\/strong><br \/>\n          <br \/>September 13-15, 2021<br \/>On-demand presentation will be available at 7:00am ET on\u00a0September 13; hosting 1-on-1 meetings <\/p>\n<\/li>\n<li>\n          <strong>Oppenheimer\u00a0Fall Healthcare Life Sciences &amp; MedTech Summit<\/strong><br \/>\n          <br \/>September 20-23, 2021<br \/>Presentation on\u00a0September 20\u00a0at\u00a04:35 pm ET; hosting 1-on-1 meetings<\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>\n          <strong>Cantor 2021 Virtual Global Healthcare Conference\u00a0<\/strong><br \/>\n          <br \/>September 27-30, 2021<br \/>Fireside chat on\u00a0September 29\u00a0at\u00a04:00 pm ET; hosting 1-on-1 meetings<\/li>\n<\/ul>\n<p>A webcast of each presentation and fireside chat will be accessible on the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NyBSCT0-E4HcstZLiYwFPk-zi9oR-laZtIhbDOeFZikTy_R9fe0Ed93aqX-VoMbIOPy4RZ_posDNeOMTcYDTLw==\" rel=\"nofollow noopener\" target=\"_blank\">Opiant website<\/a>.<\/p>\n<p>\n        <strong>About\u00a0Opiant Pharmaceuticals, Inc.\u00a0<\/strong><br \/>\n        <br \/>Opiant Pharmaceuticals, Inc., the company that developed NARCAN\u00ae Nasal Spray, is building a leading\u00a0franchise\u00a0of new medicines to combat addictions and drug overdose. For more information visit:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=baIEb3TX8Cjy4nR9rUqxDOBCDohPEw6wxESP2HkS04bb1wkIzhkAktaPTdNZqzD4LEhyPMpV9sSh6eET7VaJlQ==\" rel=\"nofollow noopener\" target=\"_blank\">www.opiant.com<\/a>.<\/p>\n<p>For Media and Investor Inquiries:<br \/>Ben Atkins, Opiant<br \/>(310) 598-5410<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CVavIpxHI-TCiRE7mdu67v0Lkz5md5DQ1x4fRgNAM-AQ0zVBuDUUJdHbJD95cGjwBwnGNNjR_gz6dr0NPPfnkIXAL3hI3K6XdUfhh6yGSiw=\" rel=\"nofollow noopener\" target=\"_blank\">batkins@opiant.com<\/a><\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNTE1NCM0Mzc1MTA3IzIwMjAwNTY=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MzY4MzczYzAtZTY2YS00ZWI2LWJlMDUtOTU3ZjRiY2Y5NDA2LTEwMzE2Mjg=\/tiny\/Opiant-Pharmaceuticals-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SANTA MONICA, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) &#8212; Opiant Pharmaceuticals, Inc.\u00a0(\u201cOpiant\u201d) (Nasdaq: OPNT) today announced that members of the company\u2019s senior management team will participate in the following virtual investor conferences: H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021On-demand presentation will be available at 7:00am ET on\u00a0September 13; hosting 1-on-1 meetings Oppenheimer\u00a0Fall Healthcare Life Sciences &amp; MedTech Summit September 20-23, 2021Presentation on\u00a0September 20\u00a0at\u00a04:35 pm ET; hosting 1-on-1 meetings Cantor 2021 Virtual Global Healthcare Conference\u00a0 September 27-30, 2021Fireside chat on\u00a0September 29\u00a0at\u00a04:00 pm ET; hosting 1-on-1 meetings A webcast of each presentation and fireside chat will be accessible on the\u00a0Opiant website. About\u00a0Opiant Pharmaceuticals, Inc.\u00a0 Opiant Pharmaceuticals, Inc., the company that developed NARCAN\u00ae Nasal Spray, is building a leading\u00a0franchise\u00a0of new &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Opiant Pharmaceuticals to Participate in September Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-531441","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Opiant Pharmaceuticals to Participate in September Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Opiant Pharmaceuticals to Participate in September Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SANTA MONICA, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) &#8212; Opiant Pharmaceuticals, Inc.\u00a0(\u201cOpiant\u201d) (Nasdaq: OPNT) today announced that members of the company\u2019s senior management team will participate in the following virtual investor conferences: H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021On-demand presentation will be available at 7:00am ET on\u00a0September 13; hosting 1-on-1 meetings Oppenheimer\u00a0Fall Healthcare Life Sciences &amp; MedTech Summit September 20-23, 2021Presentation on\u00a0September 20\u00a0at\u00a04:35 pm ET; hosting 1-on-1 meetings Cantor 2021 Virtual Global Healthcare Conference\u00a0 September 27-30, 2021Fireside chat on\u00a0September 29\u00a0at\u00a04:00 pm ET; hosting 1-on-1 meetings A webcast of each presentation and fireside chat will be accessible on the\u00a0Opiant website. About\u00a0Opiant Pharmaceuticals, Inc.\u00a0 Opiant Pharmaceuticals, Inc., the company that developed NARCAN\u00ae Nasal Spray, is building a leading\u00a0franchise\u00a0of new &hellip; Continue reading &quot;Opiant Pharmaceuticals to Participate in September Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-25T20:08:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNTE1NCM0Mzc1MTA3IzIwMjAwNTY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Opiant Pharmaceuticals to Participate in September Investor Conferences\",\"datePublished\":\"2021-08-25T20:08:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\\\/\"},\"wordCount\":161,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNTE1NCM0Mzc1MTA3IzIwMjAwNTY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\\\/\",\"name\":\"Opiant Pharmaceuticals to Participate in September Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNTE1NCM0Mzc1MTA3IzIwMjAwNTY=\",\"datePublished\":\"2021-08-25T20:08:44+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNTE1NCM0Mzc1MTA3IzIwMjAwNTY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMxNTE1NCM0Mzc1MTA3IzIwMjAwNTY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Opiant Pharmaceuticals to Participate in September Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Opiant Pharmaceuticals to Participate in September Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Opiant Pharmaceuticals to Participate in September Investor Conferences - Market Newsdesk","og_description":"SANTA MONICA, Calif., Aug. 25, 2021 (GLOBE NEWSWIRE) &#8212; Opiant Pharmaceuticals, Inc.\u00a0(\u201cOpiant\u201d) (Nasdaq: OPNT) today announced that members of the company\u2019s senior management team will participate in the following virtual investor conferences: H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021On-demand presentation will be available at 7:00am ET on\u00a0September 13; hosting 1-on-1 meetings Oppenheimer\u00a0Fall Healthcare Life Sciences &amp; MedTech Summit September 20-23, 2021Presentation on\u00a0September 20\u00a0at\u00a04:35 pm ET; hosting 1-on-1 meetings Cantor 2021 Virtual Global Healthcare Conference\u00a0 September 27-30, 2021Fireside chat on\u00a0September 29\u00a0at\u00a04:00 pm ET; hosting 1-on-1 meetings A webcast of each presentation and fireside chat will be accessible on the\u00a0Opiant website. About\u00a0Opiant Pharmaceuticals, Inc.\u00a0 Opiant Pharmaceuticals, Inc., the company that developed NARCAN\u00ae Nasal Spray, is building a leading\u00a0franchise\u00a0of new &hellip; Continue reading \"Opiant Pharmaceuticals to Participate in September Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-25T20:08:44+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNTE1NCM0Mzc1MTA3IzIwMjAwNTY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Opiant Pharmaceuticals to Participate in September Investor Conferences","datePublished":"2021-08-25T20:08:44+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/"},"wordCount":161,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNTE1NCM0Mzc1MTA3IzIwMjAwNTY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/","name":"Opiant Pharmaceuticals to Participate in September Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNTE1NCM0Mzc1MTA3IzIwMjAwNTY=","datePublished":"2021-08-25T20:08:44+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNTE1NCM0Mzc1MTA3IzIwMjAwNTY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMxNTE1NCM0Mzc1MTA3IzIwMjAwNTY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opiant-pharmaceuticals-to-participate-in-september-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Opiant Pharmaceuticals to Participate in September Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/531441","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=531441"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/531441\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=531441"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=531441"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=531441"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}